Cost Plus Drugs added the drugs to its portfolio Jan. 19, according to posts on X.
The company — which sells medications at their manufacturing price, a 15% markup and a $10 fee for shipping and handling — offers more than 4,000 drugs. Twenty are brand-name:
- Advair Diskus (fluticasone/salmeterol)
- Brenzavvy (bexagliflozin)
- CaroSpir (spironolactone)
- Climara (estradiol)
- Clomid (clomiphene citrate)
- Dexamethasone Intensol (dexamethasone)
- Duavee (conjugated estrogens/bazedoxifene)
- Estring (estradiol)
- GaviLyte-C (PEG 3350-KCl-Na bicarb-NaCl-Na sulfate)
- Invokamet (canagliflozin-metformin HCl)
- Invokamet XR (canagliflozin-metformin HCl)
- Invokana (canagliflozin)
- Nitro-Bid (nitroglycerin)
- Premarin (conjugated estrogens)
- Premphase (conjugated estrogens/medroxyprogesterone)
- Prempro (conjugated estrogens/medroxyprogesterone)
- Promethegan (promethazine HCl)
- Tirosint (levothyroxine sodium)
- Yaz (drospirenone/ethinyl estradiol)
- Yusimry (adalimumab-aqvh)
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
